Newsletter | May 2024 Recap

Samsung Biologics to attend 2024 BIO International Convention

Samsung Biologics will be sharing its strategic capacity and portfolio expansion plans at the 2024 BIO International Convention in San Diego between June 3-6. The company will also showcase its new CDO message highlighting key service elements – ‘Agile. Flexible. Focused on You.', as well as recently launched proprietary development platforms and programs. Read more

BIO INSIGHTS

Accelerating success in biologics manufacturing

A well-executed bioprocess technology transfer is essential for the success and faster market entry of a drug. Explore how Samsung Biologics consistently improves tech transfer processes, leveraging our accumulated expertise and advanced technologies, to support clients in achieving commercial success. Read more

WHITEPAPER

Given the complexity of biomanufacturing processes and the dynamic regulatory environment, effective tech transfer is essential for the on-time delivery of life-saving treatments. This whitepaper explores how we seamlessly execute tech transfers and scale-up processes, leveraging our robust MSAT expertise and advanced technologies, to ensure the success and quality of final products. Read more

SCIENTIFIC POSTER

Transient expression platform for early material

Having robust assessment tools to select biologic compounds with adequate stability and developability is crucial for successful drug development. Check out this poster on our transient gene expression platform, S-CHOsient?, and developability assessment platform, DEVELOPICK?, which enable a smooth transition of your candidates into stable cell line production. Download

Optimizing charge variant profiles of mAbs

Precise characterization of charge variants throughout the development phase is crucial to maintain consistency and quality across batches, which is key for regulatory approval and clinical success. In this poster, we explore two case studies of optimizing charge variant profiles of mAbs through targeted media and additive screening during upstream process development. Download

Minimize risk, maximize success

A comprehensive candidate screening method that can evaluate multiple attributes offers early insights and maximizes the potential for success. Watch this clip to find out about our developability assessment platform, DEVELOPICK?. Download

UPCOMING EVENTS

• For more information, visit our website.